Cytokinetics CYTK CA — Operating Leases Undiscounted Lease Payments
Discontinued — last reported Q3 '23
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept cytk:OperatingLeasesUndiscountedLeasePayments.
The official record: Cytokinetics’s 10-Q, filed November 3, 2023, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's ca — operating leases undiscounted lease payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytokinetics's CA — operating leases undiscounted lease payments?
- Cytokinetics (CYTK) reported CA — operating leases undiscounted lease payments of $211.5M in Q3 2023.
- How has Cytokinetics's CA — operating leases undiscounted lease payments changed year-over-year?
- Cytokinetics's CA — operating leases undiscounted lease payments decreased by 4.6% year-over-year, from $221.7M to $211.5M.
- What does CA — operating leases undiscounted lease payments mean?
- The total cash payments due for leases in this segment without adjusting for time value of money.
- How do you interpret CA — operating leases undiscounted lease payments?
- An increase indicates a larger total future cash obligation for leased facilities or equipment.
- How does CA — operating leases undiscounted lease payments compare across companies?
- Standard disclosure for maturity analysis of lease liabilities.